Brief: Biocept Announces Delay In Filing Of Its Quarterly Report On Form 10-Q
May 16 (Reuters) - Biocept Inc BIOC.O :
* BIOCEPT ANNOUNCES A DELAY IN THE FILING OF ITS QUARTERLY
REPORT
ON FORM 10-Q
* BIOCEPT INC - DELAY IS RELATED TO ONGOING ACCOUNTING
REVIEW OF
BIOCEPT'S FINANCIAL STATEMENTS AS OF AND FOR THREE MONTHS ENDED
MARCH 31, 2022
* BIOCEPT INC - ONGOING REVIEW IS A RESULT OF A CHANGE IN
CIRCUMSTANCES AT U.S. HEALTH RESOURCES SERVICES ADMINISTRATION
Source text for Eikon: ID:nBw6BNkr2a
Further company coverage: BIOC.O
((Reuters.Briefs@thomsonreuters.com;))
Recent news on Biocept
See all newsBrief: Biocept Says Trading Of Common Stock Will Be Suspended By Nasdaq At Opening Of Business On Oct 25
U.S. STOCKS ON THE MOVE-Overstock.com, Biocept, Birkenstock
Biocept slumps after filing for bankruptcy protection
Brief: Biocept CEO Antonino Morales Resigns
U.S. STOCKS ON THE MOVE-Albemarle, Novavax, WeWork